Scholarlink

<p>Pancreatic ductal adenocarcinoma (PDAC) remains one of the most refractory malignancies because of its dense stromal barrier and hypoxic microenvironment. Inspired by the Venus flytrap, we engineered an intelligent nanoflytrap (NT) system that performs a coordinated three stage therapeutic strategy of capture, block, and regulate for precise and sequential treatment. In the capture stage, the CGKRK containing tumor homing peptide enables dual recognition of p32 receptors that are overexpressed on tumor vasculature and PDAC cells, ensuring selective accumulation within the tumor microenvironment. The ROS responsive PLGA-TK-PEI copolymer further guarantees confined activation under oxidative stress. During the block stage, ROS triggered disassembly of NT releases the pro apoptotic peptide <sub>D</sub>(KLAKLAK)<sub>2</sub>, which disrupts mitochondrial membranes, induces apoptosis, and damages tumor vasculature, resembling the rapid closure of a flytrap. In the regulate stage, dihydroartemisinin undergoes Fe<sup>2+</sup> catalyzed cleavage to generate reactive oxygen species, triggering ferroptosis and mitigating hypoxia induced resistance. Gadolinium integration facilitates MRI guided monitoring. Transcriptomic and metabolomic analyses reveal that NT orchestrates apoptosis and ferroptosis while disturbing lipid metabolism and suppressing angiogenesis through ROS accumulation. This biomimetic capture block regulate strategy effectively overcomes stromal and hypoxic barriers, providing a promising MRI guided theranostic platform for PDAC.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Activatable nanoflytrap achieves synergistic “Capture-Block-Regulate” therapy of pancreatic ductal adenocarcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月21日

查看全文
  • Kai Guo,
  • Shuai Ren,
  • Yingying Cao,
  • Huifeng Zhang,
  • Jin Cui,
  • Li Xian Yip,
  • Ximing Wang,
  • Ying Tian,
  • Lina Song,
  • Zhongqiu Wang

摘要

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most refractory malignancies because of its dense stromal barrier and hypoxic microenvironment. Inspired by the Venus flytrap, we engineered an intelligent nanoflytrap (NT) system that performs a coordinated three stage therapeutic strategy of capture, block, and regulate for precise and sequential treatment. In the capture stage, the CGKRK containing tumor homing peptide enables dual recognition of p32 receptors that are overexpressed on tumor vasculature and PDAC cells, ensuring selective accumulation within the tumor microenvironment. The ROS responsive PLGA-TK-PEI copolymer further guarantees confined activation under oxidative stress. During the block stage, ROS triggered disassembly of NT releases the pro apoptotic peptide D(KLAKLAK)2, which disrupts mitochondrial membranes, induces apoptosis, and damages tumor vasculature, resembling the rapid closure of a flytrap. In the regulate stage, dihydroartemisinin undergoes Fe2+ catalyzed cleavage to generate reactive oxygen species, triggering ferroptosis and mitigating hypoxia induced resistance. Gadolinium integration facilitates MRI guided monitoring. Transcriptomic and metabolomic analyses reveal that NT orchestrates apoptosis and ferroptosis while disturbing lipid metabolism and suppressing angiogenesis through ROS accumulation. This biomimetic capture block regulate strategy effectively overcomes stromal and hypoxic barriers, providing a promising MRI guided theranostic platform for PDAC.

Graphical Abstract